|
|
|
Volumn 56, Issue 2, 2001, Pages 30-34
|
|
Prescribing: Keys to maximizing benefit while avoiding adverse drug effects
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR;
AMANTADINE;
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMPHOTERICIN B;
ANALGESIC AGENT;
ANTIDEPRESSANT AGENT;
ANTIINFECTIVE AGENT;
ATENOLOL;
AZTREONAM;
CARDIOVASCULAR AGENT;
CEPHALOSPORIN DERIVATIVE;
CHLORPROPAMIDE;
CILASTATIN PLUS IMIPENEM;
DICYCLOVERINE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
GLIBENCLAMIDE;
HISTAMINE H1 RECEPTOR ANTAGONIST;
HISTAMINE H2 RECEPTOR ANTAGONIST;
INSULIN;
LITHIUM;
METHYLDOPA;
MUSCLE RELAXANT AGENT;
NADOLOL;
PARACETAMOL;
PENICILLIN DERIVATIVE;
PETHIDINE;
PROCAINAMIDE;
PSYCHOTROPIC AGENT;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SALBUTAMOL;
SEDATIVE AGENT;
SPASMOLYTIC AGENT;
SULBACTAM;
SULFONAMIDE;
TETRACYCLINE DERIVATIVE;
UNINDEXED DRUG;
VANCOMYCIN;
AGED;
ALGORITHM;
DISEASE PREDISPOSITION;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG CONTRAINDICATION;
DRUG DISTRIBUTION;
DRUG INDICATION;
DRUG INDUCED DISEASE;
DRUG METABOLISM;
ELDERLY CARE;
GLOMERULUS FILTRATION RATE;
HIGH RISK POPULATION;
HUMAN;
INDIVIDUALIZATION;
PHARMACODYNAMICS;
PRESCRIPTION;
PRIMARY MEDICAL CARE;
REVIEW;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
TREATMENT OUTCOME;
AGED;
DRUG INTERACTIONS;
DRUG THERAPY;
DRUG THERAPY, COMBINATION;
HUMANS;
PATIENT COMPLIANCE;
PHARMACOKINETICS;
PRESCRIPTIONS, DRUG;
RISK FACTORS;
|
|
EID: 0035128250
PISSN: 0016867X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (16)
|
